Background
From January 2024 to January 2025, DRC reported 9,513 confirmed mpox cases and 43 deaths, representing the majority of cases in Africa. Most cases have occurred among key populations, primarily sex workers and men who have sex with men, where HIV prevalence (7–8%) exceeds the national average (1%). HIV-related immunosuppression has been linked to severe mpox outcomes and higher case fatality. In response, integrated HIV and syphilis testing was introduced into the Mpox response in Kinshasa to enhance early detection, referral and linkage.
Methods
We evaluated the feasibility and impact of integrating HIV and syphilis testing into mpox case management in Kinshasa, following WHO standard operating procedures. Preparatory activities included developing an integrated service delivery protocol, procurement plan, as well as linked health worker training. From March to July 2025, the approach was piloted in 11 high-burden health zones. Suspected mpox cases received further testing for confirmation using PCR, as well as a rapid dual HIV/syphilis test. All those we a reactive result received further HIV and syphilis testing according to national guidelines and were referred for specialized care and treatment. Programmatic data, test uptake, confirmed cases, co-infections, referrals, supply availability, and operational challenges were collected prospectively and reported weekly to PNLS and WHO.
Results
Amongst 1,525 suspected mpox cases, 1,228 (80.5%) received dual HIV/syphilis rapid testing. Mpox was confirmed in 277 cases (18.2%). Of these, 34 were confirmed HIV-positive (12.3%) and 25 syphilis-positive (9.0%). HIV prevalence among confirmed mpox cases exceeded the national average (12.3% versus 1%). All individuals were referred for care and treatment according to national policies. Severe clinical manifestations were also identified and occurred primarily in mpox/HIV co-infected patients, with case fatality reaching 28% in selected specialized treatment centers.
Conclusions
Integrating rapid HIV/syphilis testing into mpox case management in Kinshasa was feasible and effective, identifying individuals with co-infection and highlighting adverse outcomes among those with untreated HIV. This pragmatic, scalable strategy provides a roadmap for how to apply integrated approaches in response to emerging pathogens which can strengthen current and future outbreak responses. Expansion to additional provinces with integration of advanced HIV disease management is warranted to sustain impact.